John Pradko, DO
Family Medicine · Clinton Twp, MINPI 1619956497
Payments from drug & device makers
Across 383 payments — averaging $14.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- Lilly USA, LLC$949
- Pfizer$568
- Amgen$433
- Boehringer Ingelheim$416
- GSK$279
- plus $2K from 28 others
What the payments were for
- Food & beverage$5,602100%
- Education$10%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 86 | $1,193 |
| Lilly USA, LLC | 74 | $949 |
| Pfizer | 43 | $568 |
| Amgen(2 entities) | 27 | $433 |
| Boehringer Ingelheim | 18 | $416 |
| GSK | 20 | $279 |
| AstraZeneca | 18 | $265 |
| AbbVie(2 entities) | 13 | $209 |
| Novartis | 12 | $177 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $113 |
| Amarin Pharma, Inc. | 8 | $111 |
| Bayer | 5 | $102 |
| Astellas Pharma US Inc | 6 | $101 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $81 |
| E.r. Squibb & Sons, L.L.C. | 4 | $59 |
| Esperion Therapeutics, Inc. | 4 | $58 |
| Sanofi-aventis U.S. LLC | 4 | $55 |
| Exact Sciences | 3 | $55 |
| Nestle Healthcare Nutrition Inc. | 3 | $43 |
| Supernus Pharmaceuticals, Inc. | 2 | $41 |
| Xeris Pharmaceuticals, Inc. | 2 | $39 |
| Mayne Pharma Commercial LLC | 1 | $35 |
| Idorsia Pharmaceuticals US Inc | 2 | $34 |
| Teva Pharmaceuticals USA, Inc. | 2 | $27 |
| Avanir Pharmaceuticals, Inc. | 2 | $26 |
| Johnson & Johnson | 2 | $25 |
| Edwards Lifesciences | 1 | $17 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
| CMP Pharma, Inc. | 1 | $15 |
| Athena Bioscience, LLC | 1 | $14 |
| Nalpropion Pharmaceuticals LLC | 1 | $13 |
| Biohaven Pharmaceuticals, Inc. | 1 | $12 |
| Eisai Inc. | 1 | $12 |
| Shire North American Group Inc | 1 | $11 |
How this compares
$5,603 in reported general payments places this provider in the 90th percentile of 3,945 family medicine providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 102 | $113,132 |
| JardianceEmpagliflozin | 89 | $85,898 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 73 | $48,481 |
| EliquisApixaban | 44 | $48,172 |
| MounjaroTirzepatide | 28 | $44,786 |
| XareltoRivaroxaban | 50 | $39,970 |
| JanuviaSitagliptin Phosphate | 34 | $33,341 |
| MyrbetriqMirabegron | 32 | $25,487 |
| OzempicSemaglutide | 22 | $24,493 |
| OxycontinOxycodone Hcl | 13 | $23,306 |
| Repatha SureclickEvolocumab | 13 | $20,245 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 489 | $10,048 |
| ViberziEluxadoline | 12 | $9,094 |
| EntrestoSacubitril/Valsartan | 13 | $8,564 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 162 | $6,748 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $949 | $157,918130 claims |
| Boehringer IngelheimJardiance | $416 | $85,89889 claims |
| GSKTrelegy Ellipta, Anoro Ellipta | $279 | $54,80387 claims |
| PfizerEliquis | $568 | $48,17244 claims |
| Johnson & JohnsonXarelto | $25 | $39,97050 claims |
| Astellas Pharma US IncMyrbetriq | $101 | $25,48732 claims |
| Novo NordiskOzempic | $1,193 | $24,49322 claims |
| AbbVieViberzi | $209 | $9,09412 claims |
| NovartisEntresto | $177 | $8,56413 claims |
| AstraZenecaSymbicort | $265 | $5,77724 claims |
| Sanofi-aventis U.S. LLCLantus | $55 | $5,21317 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,945 family medicine providers in Michigan.
Other family medicine in Clinton Twp
- Derrick WilliamsonSouthfield$9.9M
- Rebecca RivardRoseville$7M
- Paul BensonBerkley$4.2M
- Michael HafranEast Lansing$2.7M
- Mitzie HewittBuckley$1.3M
- Loren ChudlerSouthfield$1.3M
- Solomon AmsterWhite Lake$981K
- Matt RosenbergJackson$559K
- Rhonda MejeurGrand Rapids$493K
- Steve LasaterSaint Johns$291K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.